Michael S. Rafii

2008-2016 Neuroscience University of California, San Diego, La Jolla, CA 
 2016- Neurology University of Southern California Keck School of Medicine 
Neurodegenerative Diseases
"Michael Rafii"
Mean distance: 15.77 (cluster 11)


Sign in to add mentor
Carl W. Cotman research assistant UC Irvine
Justin R. Fallon grad student 1997-2002 Brown
 (Roles for the proteoglycan biglycan in muscular dystrophy and neuromuscular junction formation.)
Leon J. Thal post-doc 2006-2008 UCSD
Paul S. Aisen research scientist 2007-2007
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rafii MS, Fortea J. (2023) Down Syndrome in a New Era for Alzheimer Disease. Jama
Rissman RA, Langford O, Raman R, et al. (2023) Plasma Aβ42/Aβ40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Leisher S, Bohorquez A, Gay M, et al. (2023) Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer's Disease. Cns Drugs
Sperling RA, Donohue MC, Raman R, et al. (2023) Trial of Solanezumab in Preclinical Alzheimer's Disease. The New England Journal of Medicine
Rafii MS, Aisen PS. (2023) Detection and treatment of Alzheimer's disease in its preclinical stage. Nature Aging. 3: 520-531
Baldaranov D, Garcia V, Miller G, et al. (2023) Safety and tolerability of lumbar puncture for the evaluation of Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 15: e12431
Boerwinkle AH, Gordon BA, Wisch J, et al. (2022) Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study. The Lancet. Neurology. 22: 55-65
Rafii MS, Sperling RA, Donohue MC, et al. (2022) The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Rafii MS, Sol O, Mobley WC, et al. (2022) Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial. Jama Neurology
Aisen PS, Jimenez-Maggiora GA, Rafii MS, et al. (2022) Early-stage Alzheimer disease: getting trial-ready. Nature Reviews. Neurology
See more...